4.6 Review

Pentosan Polysulfate Affords Pleotropic Protection to Multiple Cells and Tissues

Journal

PHARMACEUTICALS
Volume 16, Issue 3, Pages -

Publisher

MDPI
DOI: 10.3390/ph16030437

Keywords

DMOAD; cystitis; anti-viral; tissue protection; hyaluronan; endothelial cell dysfunction; anti-inflammatory

Ask authors/readers for more resources

This review outlines the potential of pentosan polysulfate (PPS) as a therapeutic agent in various disease processes. PPS exhibits tissue-protective properties and has been used in the treatment of interstitial cystitis, painful bowel disease, cartilage-related conditions, and tissue engineering. It regulates complement activation, coagulation, and fibrinolysis, promotes hyaluronan synthesis, inhibits nerve growth factor production, removes fatty compounds, and regulates cytokine production. PPS also acts as an anti-tumor agent and stimulates the proliferation and differentiation of stem cells. Overall, PPS is a multifunctional molecule with therapeutic potential for a diverse range of diseases.
Pentosan polysulfate (PPS), a small semi-synthetic highly sulfated heparan sulfate (HS)-like molecule, shares many of the interactive properties of HS. The aim of this review was to outline the potential of PPS as an interventional therapeutic protective agent in physiological processes affecting pathological tissues. PPS is a multifunctional molecule with diverse therapeutic actions against many disease processes. PPS has been used for decades in the treatment of interstitial cystitis and painful bowel disease, it has tissue-protective properties as a protease inhibitor in cartilage, tendon and IVD, and it has been used as a cell-directive component in bioscaffolds in tissue engineering applications. PPS regulates complement activation, coagulation, fibrinolysis and thrombocytopenia, and it promotes the synthesis of hyaluronan. Nerve growth factor production in osteocytes is inhibited by PPS, reducing bone pain in osteoarthritis and rheumatoid arthritis (OA/RA). PPS also removes fatty compounds from lipid-engorged subchondral blood vessels in OA/RA cartilage, reducing joint pain. PPS regulates cytokine and inflammatory mediator production and is also an anti-tumor agent that promotes the proliferation and differentiation of mesenchymal stem cells and the development of progenitor cell lineages that have proven to be useful in strategies designed to effect repair of the degenerate intervertebral disc (IVD) and OA cartilage. PPS stimulates proteoglycan synthesis by chondrocytes in the presence or absence of interleukin (IL)-1, and stimulates hyaluronan production by synoviocytes. PPS is thus a multifunctional tissue-protective molecule of potential therapeutic application for a diverse range of disease processes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available